GlassScriptPhysician profile
Thomas Constantine Lowrey
NPI 1174013916
$6,045.82
in general payments reported to CMS, 2019-2025
29 companies · $1,072 in 2025
The $1,072 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $77.18 · 2023: $1,055 · 2024: $3,737 · 2025: $1,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,148 · Travel and Lodging: $2,630 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,148.10 |
| Travel and Lodging | $2,629.98 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,082.32 | 2024-2025 | Nanoknife |
| Procept Biorobotics Corporation | $966.22 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $616.96 | 2021-2024 | Solyx Sis System, Rezum Generator, Ams 700 Cxr Rte Kit |
| Cook Incorporated | $512.47 | 2023 | Fiber Dust |
| Medtronic, INC. | $437.57 | 2024-2025 | Interstim |
| Teleflex LLC | $143.23 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $102.42 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $100.65 | 2024-2025 | Adstiladrin, Firmagon |
| Abbvie INC. | $99.80 | 2024-2025 | |
| Janssen Biotech, INC. | $99.58 | 2024-2025 | Erleada, Akeega |
| Urogen Pharma, INC. | $89.01 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $87.81 | 2023-2024 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $84.99 | 2023 | Lynparza |
| Biotissue Holdings INC. | $84.21 | 2024-2025 | |
| Astellas Pharma US INC | $77.53 | 2023-2025 | Xtandi, Myrbetriq |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $66.47 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $62.68 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $55.79 | 2025 | |
| Becton, Dickinson and Company | $51.85 | 2023 | Bard Urinary Drainage Bag |
| Convatec INC. | $28.39 | 2023 | |
| Verity Pharmaceuticals INC. | $24.90 | 2025 | Trelstar |
| Blue Earth Diagnostics | $24.52 | 2024 | |
| Progenics Pharmaceuticals, INC. | $24.41 | 2025 | |
| Alnylam Pharmaceuticals INC. | $24.33 | 2024 | Oxlumo |
| 180 Medical, INC. | $23.44 | 2024 | |
| Profound Medical Corp. | $21.89 | 2025 | Tulsa-Pro |
| Accord Healthcare, INC. | $18.55 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.47 | 2024 | |
| Myriad Genetic Laboratories, INC. | $16.36 | 2025 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lowrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.